Emerging concepts for immune checkpoint blockade-based combination therapies Journal Article


Authors: Zappasodi, R.; Merghoub, T.; Wolchok, J. D.
Article Title: Emerging concepts for immune checkpoint blockade-based combination therapies
Abstract: Checkpoint blockade has formally demonstrated that reactivating anti-tumor immune responses can regress tumors. However, this only occurs in a fraction of patients. Incorporating these therapies in more powerful combinations is thus a logical next step. Here, we review functional roles of immune checkpoints and molecular determinants of checkpoint-blockade clinical activity. Limited-size T cell-infiltrated tumors, differing substantially from “self,” generally respond to checkpoint blockade. Therefore, we propose that reducing tumor burden and increasing tumor immunogenicity are key factors to improve immunotherapy. Lastly, we outline criteria to select proper immunotherapy combination partners and highlight the importance of activity biomarkers for timely treatment optimization. Checkpoint blockade has formally demonstrated that reactivating anti-tumor immune responses can regress tumors. However, this only occurs in a fraction of patients. Incorporating these therapies in more powerful combinations is thus a logical next step. Here, we review functional roles of immune checkpoints and molecular determinants of checkpoint-blockade clinical activity. Limited-size T cell-infiltrated tumors, differing substantially from “self,” generally respond to checkpoint blockade. Therefore, we propose that reducing tumor burden and increasing tumor immunogenicity are key factors to improve immunotherapy. Lastly, we outline criteria to select proper immunotherapy combination partners and highlight the importance of activity biomarkers for timely treatment optimization. © 2018 Elsevier Inc.
Keywords: cancer immunotherapy; tumor immunology; immune checkpoint blockade; immunotherapy-based combinations
Journal Title: Cancer Cell
Volume: 33
Issue: 4
ISSN: 1535-6108
Publisher: Cell Press  
Date Published: 2018-04-09
Start Page: 581
End Page: 598
Language: English
DOI: 10.1016/j.ccell.2018.03.005
PROVIDER: scopus
PMCID: PMC5896787
PUBMED: 29634946
DOI/URL:
Notes: Review -- Export Date: 1 May 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok
  2. Taha Merghoub
    364 Merghoub